Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04825860 |
| Consolidated Lead Sponsor | Sumitomo Pharma Co |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 83 participants (ACTUAL) |
| Registered Start Date | 2021-03-29 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.